When

26th to 27th October 2017
Starting at 8am

Where

Porto, Portugal
Venue to be announced

Super Early Bird Tickets ends on July 7th!

Register now Request Brochure

BioTech Pharma Summit 2017
Companion Diagnostics & Biomarkers

The BioTech Pharma Summit 2017: Companion Diagnostics & Biomarkers edition, to be held on October 26-27, 2017 in Porto, Portugal is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

Overview

After a sold-out first edition in March 2017, this second edition will feature on the importance of partnerships formed between and among pharma, diagnostics, and CROs to coordinate development and implementation of the drug-diagnostics pair. Talks will highlight strategy, tactics, and lessons learned as clinical trials and marketing efforts unfold.

Benefits of attending

The summit as an executive format where case study presentations and panel discussions enable an interactive exchange of ideas and experiences, you will be able to have many networking opportunities with senior peers and get post event follow up offering all documentation from the meeting and re-booking discounts.

Who should attend?

The BioTech Pharma Summit: Companion Diagnostics & Biomarkers edition is an exclusive event consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based mainly in Europe but also worldwide.

Key Speakers

Master classes from World CDx & Biomarkers experts: Request brochure to see all speakers

Nick
Zhang, CN

Chairman and CEO at QIAGEN Translational Medicine

Read his biography >>

Henrik
Winther, SE

SVP Business Development at ‎Immunovia

Read his biography >>

Anand
Subramony, US

Vice President of Novel Product Technologies at MedImmune

Read his biography >>

Robert
Hawkins, UK

Cancer Research UK Professor at University of Manchester

Read his biography >>

Paul
Whittaker, UK

Vice President Discovery Research at hVIVO

Read his biography >>

Jeffrey
Jones, US

Executive Vice President, Commercial Operations at SkylineDx BV

Read his biography >>

Ashok
C. Chander, US

CEO at Cellanyx Diagnostics

Read his biography >>

Christopher
Ung, US

Chief Business Officer at HistoGeneX

Read his biography >>

Major Conference Sections

That's not all, please request the brochure to see all sections! 2-days Summit full of Master-classes, Panel discussions & Interactive sessions.

8:50 am

The changing face of healthcare: dawn of individualized medicine

Dr. Harry Glorikian, US
CEO at Harry Glorikian & Advisory Board at Evidation Health

– Shift to data driven and evidence based system to support value based health and healthcare decisions
– Efficient and effective use of genetic and molecular characterization to shape the way medicine is practiced and the way drugs are approved
– Greater integration of discovery, clinical trials, and ongoing clinical care to transform evidence generation for improved healthcare decisions

11:10 am

Biomarker and CDx – the first half of Precision Medicine

Dr. Nick Zhang, CN
Chairman and CEO at QIAGEN (Suzhou) Translational Medicine Co. Ltd.

– Overview of biomarker and CDx
– Our CDx business model and case studies
– Biomarker and CDx development in China.

12:30 pm

Adoptive cell therapy for cancer using both natural and engineered T-cells

Prof. Robert Hawkins, UK
Cancer Research UK Professor at University of Manchester

5:10 pm

Personalized Oncology Solutions: Live Cell Behavior

Dr. Ashok Chander, US
CEO, Cellanyx

– Understanding the aggressiveness of cancer is the next big challenge in personalized medicine.
– Tumor heterogeneity is a major biological obstacle towards personalized medicine.
– Live Cell Phenotypic Diagnostics on primary biopsy cells is a powerful solution to understanding tumor heterogeneity.
– Emerging clinical evidence support Live Cell Phenotypic Diagnostics as an important addition to genomic technology as well as a potential new technology and class of diagnostics for personalized medicine.

9:00 am

Non-invasive Imaging based Companion Diagnostics: A Novel Approach

Dr. Susanta K. Sarkar, US
President at CadenzaMed LLC Adjunct Associate Professor at University of Pennsylvania

– Need for companion diagnostics in drug development
– Why Non-invasive Imaging approach: Background
– Impact of Imaging based companion diagnostics

9:40 am

Enabling patient centric medicine

Anand Subramony, US
Vice President, Novel Product Technologies at MedImmune

– Novel product development
– Patient centricity
– Digital health
– Controlled release and drug delivery
– Precision medicine

11:30 am

Digital Pathology in Immuno-Oncology – A Roadmap for Clinical Development

Christopher Ung, US
Chief Business Officer at HistoGeneX

– Immuno-oncology has catalyzed histopathology applications, such as TIL location and spatial analyses, that benefit from digital pathology.
– Digital Pathology validation models are present for manufacturers and diagnostics but needed for clinical development.
– The rapid evolution of PD-L1 scoring algorithms create an acute need for pathologist training and proficiency. A well-designed training module addresses these needs

2:40 pm

Overcoming challenges in the global commercialization of novel biomarkers

Jeffrey Jones, US
Vice President, Commercial Operations at SkylineDx

Building a comprehensive market access strategy – develop and validate your opportunity first.
Generating powerful evidence – start your publication planning early.
Communicating a compelling value proposition – leveraging an insight-driven commercialization strategy.

5:30 pm

Strategic Partnerships for CDx – Challenges and Opportunities

Henrik Winther
Senior Vice President, Precision Diagnostics at Immunovia AB

– What is required to become a successful CDx provider?
– What are the major challenges?
– How could these challenges potentially be solved?
– Trusted partnership is key within Rx-CDx development

Testimonials

Thank you for organising such a well managed conference. The experience and interaction with other members was really great.

Abhishek Kulshrestha
Principal Scientific Manager R&D - Biocon

I have to congratulate EPM Group on a high quality conference. I was genuinely impressed.

Dr. Uwe Gudat
Head of Safety, Biosimilars - Merck Biosimilars

I was pleased with the quality of people represented in this event.

Javier Camposano
Managing Director - Drug Product Division - Celltrion Inc.

Thank you so much for this nice conference in Porto. It was a very nice event and the organization was very well done. Thank you for your kind hospitality in this beautiful city.

Dr. Dora Marta
Regulatory Affairs, Biotechnological Products - Gedeon Richter Plc

I enjoyed the conference, which I felt was just the right size and with the right people in it. It was a very open, interactive forum for all of us and provided us an opportunity to speak out or subject related thoughts, concerns and get perspectives from other subject experts.

Samir Kulkarni
Associate Vice President, Intas Pharmaceuticals, R&D

Why is this conference for you?

Fresh Agenda

With all the fascinating feedback we’ve heard from our last edition, we’re putting together an agenda this year that’s packed with fresh, new insights and that addresses the most up-to-date issues and challenges in drug-diagnostic co-development with a great line-up of worldwide speakers.

Networking Opportunities

Join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts to advance CDx & biomarker discovery and development, the BioTech Pharma summit will assemble leading scientists, researchers, decision-makers and other players across the industry spectrum.

Wide variety of important topics

A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more.

Biomarker & Companion Diagnostics specialists

The BioTech Pharma Summit has been designed by leading biomarker and companion diagnostics specialists at Roche, Novartis, Johnson & Johnson, GSK, Merck, AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Pfizer and many more to assist you in turning biomarker research into successful patient stratification and to deliver better, safer drugs to market with drug-diagnostic co-development.

Pricing & Registration

Only 150 available seats Get your Conference Tickets early.

All Delegate Fees below includes: 2 days Summit + Master Classes + Interactive Sessions; Discussion with Industry Experts; Coffee Breaks and Business Lunches. Select your ticket and fill out the information below

Fill out your information

€ 1195

Super Early Bird Ends July 7th

Buy the the conference package for a special price and save 700€

€ 1895

Conference Package

Not Available. Starts on the 8th of July.

€ 599

Non-Profit or Academic Fee

Fee for members of academic, government institutions or non-profit organizations.

2390€

Group Discount SAVE NOW

3 for the price of 2. Select this option if you would like to register 3 delegates.

Sponsors & Partners

Interested in becoming a sponsor or Exhibit? Get in touch

  • TAP Portugal
  • Porto and the North
  • BioPharma Asia
  • LabioTech

Location and Venue

The heart of the business district in Porto

Venue to be announced

Conference Location

Porto, Portugal

Porto has all the charm of towns which happily cohabit with their river. You can stroll along the River Douro (river of gold) in Cais da Ribeira, fly over it by helicopter or discover Porto’s architecture, its amazing landscapes and magnificent bridges by taking a cruise on this majestic river. Porto is also a sea city and in the briefest of time a tram will bring you to Foz do Douro’s gentle beaches face to face with the Atlantic.

Porto, Portugal

Nearby Accomodation

The Yeatman Hotel

Awarded a Michelin star in the 2012 and 2013 Guides, the restaurant The Yeatman offers a unique dining experience, with a criative cuisine where traditional flavors are presented in a contemporary style. The hotel also has the largest wine cellar in the world of Portuguese wines; the Spa Vinothérapie ® by Caudalie, distinguished as the Best Spa in Europe and Dick’s Bar, open 24 hours.

Rua do Choupelo (Santa Marinha) | 4400-088 Vila Nova de Gaia.

Book Online

Holiday Inn Porto – Gaia

Holiday Inn Porto Gaia is a 5-minute drive of Porto city centre and just 2 km from the Port Wine Cellars. Porto Congress Centre is just 7 km away.

Rua Diogo Macedo, 220 Vila Nova de Gaia Porto

Book Online
Additional details

Need transport? Install the Cabify App here and use the Promo Code: BIOTECH17 Have any questions? Feel free to contact diogo.ribeiro[at]epmgroup.org or by phone: +351 915 239 640